RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Self-care of hypertension of older adults during COVID-19 lockdown period: a randomized controlled trial

        Khitam Alsaqer,Hatice Bebis 대한고혈압학회 2022 Clinical Hypertension Vol.28 No.-

        COVID-19 pandemic has aggravated chronic diseases and health disparities especially hypertension because it is more common among vulnerable populations such as older adults.This study aimed to examine the effects of a public health nursing intervention plus m-Health applications for hypertension management on enhancing the self-care, systolic and diastolic of blood pressure, and quality of life in older adults during the lockdown period in Jordan. A randomized, controlled trial design was performed in Jordan. A total of 120 participants were randomly allocated to three groups ( n = 40); interventional group (public health nursing interventions plus m.Health applications) and two control groups (m.Health applications alone group and standard care group). After 3 months, the interventional group show significantly decreased in systolic blood pressure − 14 ( F = 16.74, P = 0.001), greater improvement in self-care maintenance, monitoring, and confidence (+ 30, + 17.75, + 40.27; P < 0.01, respectively) compared to the two control groups. Greater improvement in role limitations due to physical health and due to emotional problems, pain, energy/fatigue, emotional well-being, and social functioning of quality of life ( P < 0.05) compared to the standard care group. No statistical significant difference was found in diastolic blood pressure ( F = 3.91, P = 0.141), physical functioning ( P = 0.613), and general quality of life ( P = 0.060). This study supports the adoption of technology with nursing intervention as a method of supporting continuity of self-management of chronic illness during the pandemic, and its potential implications for future delivery of health care, not just in Jordan, but across the world. Clinical Trial.gov (ID NCT04992000 ). Registered August 12, 2021. COVID-19 pandemic has aggravated chronic diseases and health disparities especially hypertension because it is more common among vulnerable populations such as older adults.This study aimed to examine the effects of a public health nursing intervention plus m-Health applications for hypertension management on enhancing the self-care, systolic and diastolic of blood pressure, and quality of life in older adults during the lockdown period in Jordan. A randomized, controlled trial design was performed in Jordan. A total of 120 participants were randomly allocated to three groups ( n = 40); interventional group (public health nursing interventions plus m.Health applications) and two control groups (m.Health applications alone group and standard care group). After 3 months, the interventional group show significantly decreased in systolic blood pressure − 14 ( F = 16.74, P = 0.001), greater improvement in self-care maintenance, monitoring, and confidence (+ 30, + 17.75, + 40.27; P < 0.01, respectively) compared to the two control groups. Greater improvement in role limitations due to physical health and due to emotional problems, pain, energy/fatigue, emotional well-being, and social functioning of quality of life ( P < 0.05) compared to the standard care group. No statistical significant difference was found in diastolic blood pressure ( F = 3.91, P = 0.141), physical functioning ( P = 0.613), and general quality of life ( P = 0.060). This study supports the adoption of technology with nursing intervention as a method of supporting continuity of self-management of chronic illness during the pandemic, and its potential implications for future delivery of health care, not just in Jordan, but across the world. Clinical Trial.gov (ID NCT04992000 ). Registered August 12, 2021.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼